Development of a process control strategy for the serum-free microcarrier expansion of human mesenchymal stem cells towards cost-effective and commercially viable manufacturing (2019)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bej.2018.10.018
Publication URI: http://dx.doi.org/10.1016/j.bej.2018.10.018
Type: Journal Article/Review
Parent Publication: Biochemical Engineering Journal